{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:54:57Z","timestamp":1777488897253,"version":"3.51.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a rising health issue linked to poor diet and gut microbiota dysbiosis. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, high in polyphenols and anti-inflammatory nutrients, may help protect against MASLD. This study examined how adherence to the MIND diet relates to MASLD severity, focusing on hepatic steatosis, fibrosis, insulin resistance, inflammation, and gut microbiota diversity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional analysis of 450 adults with confirmed MASLD was conducted. MIND diet scores were derived from a validated FFQ. Hepatic outcomes were assessed via ultrasonography, hepatic steatosis index (HSI), controlled attenuation parameter (CAP), and fibrosis-4 (FIB-4) index. Biomarkers included liver enzymes (ALT, AST, GGT, and ALP), HOMA-IR, lipid profile, C-reactive protein (CRP), lipopolysaccharide (LPS), and trimethylamine N-oxide (TMAO). Gut microbiota composition was analyzed using 16S rRNA sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Higher MIND scores were associated with reduced steatosis as measured by HSI and CAP, lower fibrosis indicated by the FIB-4 index, improved insulin sensitivity reflected by lower HOMA-IR values, decreased liver enzyme levels, and a more favorable lipid profile. Inflammatory markers (CRP, LPS) decreased with higher adherence (all <jats:italic>p<\/jats:italic> &amp;lt; 0.001). Each 1-unit increase in MIND diet score was significantly associated with reductions in fasting insulin (\u03b2 = \u22120.20 \u03bcU\/mL; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), HOMA-IR (\u03b2 = \u22122.11; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), CRP (\u03b2 = \u22122.12; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), LPS (\u03b2 = \u22128.52; <jats:italic>p<\/jats:italic> &amp;lt; 0.001). Notably, Simpson diversity index scores were higher, and the Firmicutes-to-Bacteroidetes ratio (F\/B ratio) was lower, among participants with greater MIND adherence, reflecting improved microbial balance. Mediation analysis revealed that Simpson diversity partially mediated the relationship between MIND score and liver health indicators, suggesting a role for gut microbial diversity in modulating hepatic outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Greater adherence to the MIND diet was associated with indicators of better liver function, lower systemic inflammation, and improved metabolic health, and a more favorable gut microbiota composition in adults with MASLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1637572","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T04:10:23Z","timestamp":1756095023000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["MIND diet score and its association with metabolic dysfunction-associated steatotic liver disease and gut microbiota profiles: a cross-sectional study"],"prefix":"10.3389","volume":"12","author":[{"given":"Shengbo","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Litao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weina","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2024","journal-title":"Clin Mol Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ueg2.12525","article-title":"Therapeutic management of metabolic dysfunction associated steatotic liver disease","volume":"12","author":"Zeng","year":"2024","journal-title":"United European Gastroenterol J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3390\/ijms26072959","article-title":"Metabolic-dysfunction-associated steatotic liver disease: molecular mechanisms, clinical implications, and emerging therapeutic strategies","volume":"26","author":"Mej\u00eda-Guzm\u00e1n","year":"2025","journal-title":"Int J Mol Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/nbu.12707","article-title":"Mediterranean diet for the management of metabolic dysfunction-associated steatotic liver disease in non-Mediterranean, Western countries: what's known and what's needed?","volume":"49","author":"Sualeheen","year":"2024","journal-title":"Nutr Bull"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.114832","article-title":"Dietary determinants of metabolic syndrome: focus on the obesity and metabolic dysfunction-associated steatotic liver disease (MASLD)","volume-title":"Metabolic Syndrome-Lifestyle and Biological Risk Factors","author":"Verma","year":"2024"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1039\/D1FO02069B","article-title":"Adherence to the MIND diet and the risk of cardiovascular disease in adults: a cohort study","volume":"13","author":"Golzarand","year":"2022","journal-title":"Food Funct."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1039\/D4FO00641K","article-title":"Greater adherence to the mediterranean dietary approaches to stop hypertension intervention for neurodegenerative delay (MIND) diet is associated with lower risk of inflammatory bowel disease: a prospective cohort study","volume":"15","author":"Ye","year":"2024","journal-title":"Food Function"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2259","DOI":"10.1212\/WNL.0000000000207176","article-title":"Association of mediterranean-DASH intervention for neurodegenerative delay and mediterranean diets with Alzheimer disease pathology","volume":"100","author":"Agarwal","year":"2023","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/antiox9080669","article-title":"Interaction of polyphenols as antioxidant and anti-inflammatory compounds in brain\u2013liver\u2013gut axis","volume":"9","author":"Singh","year":"2020","journal-title":"Antioxidants"},{"key":"B11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern Emerg Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/nu11102393","article-title":"Food components and dietary habits: keys for a healthy gut microbiota composition","volume":"11","author":"Rinninella","year":"2019","journal-title":"Nutrients."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.clnu.2022.06.037","article-title":"The effectiveness and acceptability of mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"41","author":"Haigh","year":"2022","journal-title":"Clin Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.3390\/nu14153186","article-title":"Adherence to mediterranean diet and NAFLD in patients with metabolic syndrome: the FLIPAN study","volume":"14","author":"Montemayor","year":"2022","journal-title":"Nutrients"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/antiox12071318","article-title":"Adherence to Mediterranean diet: any association with NAFLD?","volume":"12","author":"Barrea","year":"2023","journal-title":"Antioxidants."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1017\/S0007114522002318","article-title":"Validity and reproducibility of a FFQ for assessing dietary intake among residents of northeast China: northeast cohort study of China","volume":"129","author":"Cui","year":"2023","journal-title":"Br J Nutr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0007114524001892","article-title":"Development of the Dutch Mediterranean-dietary approaches to stop hypertension intervention for neurodegenerative delay (MIND) diet and its scoring system, alongside the modification of a brief FFQ for assessing dietary adherence","volume":"2024","author":"Beers","year":"","journal-title":"Br J Nutr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1078961","DOI":"10.3389\/fnut.2023.1078961","article-title":"Associations between adherence to MIND diet and general obesity and lipid profile: a cross-sectional study","volume":"10","author":"Fateh","year":"2023","journal-title":"Front Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5114\/ceh.2021.104543","article-title":"FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study","volume":"7","author":"Catanzaro","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41598-024-77864-y","article-title":"Key features and guidelines for the application of microbial alpha diversity metrics","volume":"15","author":"Cassol","year":"2025","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1574-6941.2009.00671.x","article-title":"Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR","volume":"68","author":"Furet","year":"2009","journal-title":"FEMS Microbiol Ecol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/02601060221127461","article-title":"Associations between adherence to the MIND diet and prevalence of psychological disorders, and sleep disorders severity among obese and overweight women: a cross-sectional study","volume":"30","author":"Seifollahi","year":"2024","journal-title":"Nutr Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/antiox10081172","article-title":"Potential antioxidant and anti-inflammatory properties of serum from healthy adolescents with optimal Mediterranean diet adherence: findings from DIMENU cross-sectional study","volume":"10","author":"Augimeri","year":"2021","journal-title":"Antioxidants."},{"key":"B24","doi-asserted-by":"publisher","first-page":"104470","DOI":"10.1016\/j.tifs.2024.104470","article-title":"Anti-obesogenic effects of plant natural products: a focus on Korean traditional foods","volume":"148","author":"Das","year":"2024","journal-title":"Trends Food Sci Technol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/nu13020494","article-title":"Dietary polyphenols and non-alcoholic fatty liver disease","volume":"13","author":"Abenavoli","year":"2021","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1192099","DOI":"10.3389\/fpubh.2023.1192099","article-title":"Omega-3 intake is associated with liver disease protection","volume":"11","author":"Vell","year":"2023","journal-title":"Front Public Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"585876","DOI":"10.1155\/2013\/585876","article-title":"Increasing whole grain intake as part of prevention and treatment of nonalcoholic fatty liver disease","volume":"2013","author":"Ross","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-3-319-59180-3_10","article-title":"Dietary patterns, foods, nutrients and phytochemicals in non-alcoholic fatty liver disease","author":"Dreher","year":"2018","journal-title":"Dietary Patterns and Whole Plant Foods in Aging and Disease"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/nutrit\/nuaa148","article-title":"Extra-virgin olive oil and the gut-brain axis: influence on gut microbiota, mucosal immunity, and cardiometabolic and cognitive health","volume":"79","author":"Millman","year":"2021","journal-title":"Nutr Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0007114524001168","article-title":"The effects of MIND diet on depression, anxiety, quality of life and metabolic and hormonal status in obese or overweight women with polycystic ovary syndrome: a randomised clinical trial","volume":"28","author":"Kabiri","year":"2024","journal-title":"Br J Nutr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.3390\/nu13103453","article-title":"Pathobiological relationship of excessive dietary intake of choline\/L-carnitine: a TMAO precursor-associated aggravation in heart failure in Sarcopenic patients","volume":"13","author":"Bin-Jumah","year":"2021","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1085041","DOI":"10.3389\/fendo.2023.1085041","article-title":"The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases","volume":"14","author":"Zhen","year":"2023","journal-title":"Front Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/j.2040-4603.2022.tb00205.x","article-title":"Bile acids, gut microbiome and the road to fatty liver disease","volume":"12","author":"Hylemon","year":"2022","journal-title":"Comprehensive Physiology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","article-title":"Intestinal barrier dysfunction, LPS translocation, disease development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J Endocr Soc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"775526","DOI":"10.3389\/fimmu.2021.775526","article-title":"The gut-liver axis in health and disease: the role of gut microbiota-derived signals in liver injury and regeneration","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"703218","DOI":"10.3389\/fcell.2021.703218","article-title":"The role of short-chain fatty acids and bile acids in intestinal and liver function, inflammation, and carcinogenesis","volume":"9","author":"Visekruna","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1294267","DOI":"10.3389\/fmed.2023.1294267","article-title":"Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic","volume":"10","author":"Rao","year":"2023","journal-title":"Front Med"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1637572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T04:10:24Z","timestamp":1756095024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1637572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":39,"alternative-id":["10.3389\/fnut.2025.1637572"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1637572","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"article-number":"1637572"}}